ASTRAZENECA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,124 GBX | -0.35% |
|
-1.81% | +14.58% |
| May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
| May. 16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -0.16% | -1.81% | +14.58% | +1.86% | +106.74% | 239B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
